Definition of bulky disease in early stage hodgkin lymphoma in computed tomography era: Prognostic significance of measurements in the coronal and transverse planes

Anita Kumar, Irene A. Burger, Zhigang Zhang, Esther N. Drill, Jocelyn C. Migliacci, Andrea Ng, Ann Lacasce, Darci Wall, Thomas E. Witzig, Kay Ristow, Joachim Yahalom, Craig Moskowitz, Andrew D. Zelenetz

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Disease bulk is an important prognostic factor in early stage Hodgkin lymphoma, but its definition is unclear in the computed tomography era. This retrospective analysis investigated the prognostic significance of bulky disease measured in transverse and coronal planes on computed tomography imaging. Early stage Hodgkin lymphoma patients (n=185) treated with chemotherapy with or without radiotherapy from 2000-2010 were included. The longest diameter of the largest lymph node mass was measured in transverse and coronal axes on pre-treatment imaging. The optimal cut off for disease bulk was maximal diameter greater than 7 cm measured in either the transverse or coronal plane. Thirty patients with maximal transverse diameter of 7 cm or under were found to have bulk in coronal axis. The 4-year overall survival was 96.5% (CI: 93.3%, 100%) and 4-year relapse-free survival was 86.8% (CI: 81.9%, 92.1%) for all patients. Relapse-free survival at four years for bulky patients was 80.5% (CI: 73%, 88.9%) compared to 94.4% (CI: 89.1%, 100%) for non-bulky; Cox HR 4.21 (CI: 1.43, 12.38) (P=0.004). In bulky patients, relapse-free survival was not impacted in patients treated with chemoradiotherapy; however, it was significantly lower in patients treated with chemotherapy alone. In an independent validation cohort of 38 patients treated with chemotherapy alone, patients with bulky disease had an inferior relapse-free survival [at 4 years, 71.1% (CI: 52.1%, 97%) vs. 94.1% (CI: 83.6%, 100%), Cox HR 5.27 (CI: 0.62, 45.16); P=0.09]. Presence of bulky disease on multidimensional computed tomography imaging is a significant prognostic factor in early stage Hodgkin lymphoma. Coronal reformations may be included for routine Hodgkin lymphoma staging evaluation. In future, our definition of disease bulk may be useful in identifying patients who are most appropriate for chemotherapy alone.

Original languageEnglish (US)
Pages (from-to)1237-1243
Number of pages7
JournalHaematologica
Volume101
Issue number10
DOIs
StatePublished - Sep 30 2016
Externally publishedYes

Fingerprint

Hodgkin Disease
Tomography
Survival
Recurrence
Drug Therapy
Chemoradiotherapy
Radiotherapy
Lymph Nodes

ASJC Scopus subject areas

  • Hematology

Cite this

Definition of bulky disease in early stage hodgkin lymphoma in computed tomography era : Prognostic significance of measurements in the coronal and transverse planes. / Kumar, Anita; Burger, Irene A.; Zhang, Zhigang; Drill, Esther N.; Migliacci, Jocelyn C.; Ng, Andrea; Lacasce, Ann; Wall, Darci; Witzig, Thomas E.; Ristow, Kay; Yahalom, Joachim; Moskowitz, Craig; Zelenetz, Andrew D.

In: Haematologica, Vol. 101, No. 10, 30.09.2016, p. 1237-1243.

Research output: Contribution to journalArticle

Kumar, A, Burger, IA, Zhang, Z, Drill, EN, Migliacci, JC, Ng, A, Lacasce, A, Wall, D, Witzig, TE, Ristow, K, Yahalom, J, Moskowitz, C & Zelenetz, AD 2016, 'Definition of bulky disease in early stage hodgkin lymphoma in computed tomography era: Prognostic significance of measurements in the coronal and transverse planes', Haematologica, vol. 101, no. 10, pp. 1237-1243. https://doi.org/10.3324/haematol.2016.141846
Kumar, Anita ; Burger, Irene A. ; Zhang, Zhigang ; Drill, Esther N. ; Migliacci, Jocelyn C. ; Ng, Andrea ; Lacasce, Ann ; Wall, Darci ; Witzig, Thomas E. ; Ristow, Kay ; Yahalom, Joachim ; Moskowitz, Craig ; Zelenetz, Andrew D. / Definition of bulky disease in early stage hodgkin lymphoma in computed tomography era : Prognostic significance of measurements in the coronal and transverse planes. In: Haematologica. 2016 ; Vol. 101, No. 10. pp. 1237-1243.
@article{9aa80022243c4ba6a529fcd0a7aef9df,
title = "Definition of bulky disease in early stage hodgkin lymphoma in computed tomography era: Prognostic significance of measurements in the coronal and transverse planes",
abstract = "Disease bulk is an important prognostic factor in early stage Hodgkin lymphoma, but its definition is unclear in the computed tomography era. This retrospective analysis investigated the prognostic significance of bulky disease measured in transverse and coronal planes on computed tomography imaging. Early stage Hodgkin lymphoma patients (n=185) treated with chemotherapy with or without radiotherapy from 2000-2010 were included. The longest diameter of the largest lymph node mass was measured in transverse and coronal axes on pre-treatment imaging. The optimal cut off for disease bulk was maximal diameter greater than 7 cm measured in either the transverse or coronal plane. Thirty patients with maximal transverse diameter of 7 cm or under were found to have bulk in coronal axis. The 4-year overall survival was 96.5{\%} (CI: 93.3{\%}, 100{\%}) and 4-year relapse-free survival was 86.8{\%} (CI: 81.9{\%}, 92.1{\%}) for all patients. Relapse-free survival at four years for bulky patients was 80.5{\%} (CI: 73{\%}, 88.9{\%}) compared to 94.4{\%} (CI: 89.1{\%}, 100{\%}) for non-bulky; Cox HR 4.21 (CI: 1.43, 12.38) (P=0.004). In bulky patients, relapse-free survival was not impacted in patients treated with chemoradiotherapy; however, it was significantly lower in patients treated with chemotherapy alone. In an independent validation cohort of 38 patients treated with chemotherapy alone, patients with bulky disease had an inferior relapse-free survival [at 4 years, 71.1{\%} (CI: 52.1{\%}, 97{\%}) vs. 94.1{\%} (CI: 83.6{\%}, 100{\%}), Cox HR 5.27 (CI: 0.62, 45.16); P=0.09]. Presence of bulky disease on multidimensional computed tomography imaging is a significant prognostic factor in early stage Hodgkin lymphoma. Coronal reformations may be included for routine Hodgkin lymphoma staging evaluation. In future, our definition of disease bulk may be useful in identifying patients who are most appropriate for chemotherapy alone.",
author = "Anita Kumar and Burger, {Irene A.} and Zhigang Zhang and Drill, {Esther N.} and Migliacci, {Jocelyn C.} and Andrea Ng and Ann Lacasce and Darci Wall and Witzig, {Thomas E.} and Kay Ristow and Joachim Yahalom and Craig Moskowitz and Zelenetz, {Andrew D.}",
year = "2016",
month = "9",
day = "30",
doi = "10.3324/haematol.2016.141846",
language = "English (US)",
volume = "101",
pages = "1237--1243",
journal = "Haematologica",
issn = "0390-6078",
publisher = "Ferrata Storti Foundation",
number = "10",

}

TY - JOUR

T1 - Definition of bulky disease in early stage hodgkin lymphoma in computed tomography era

T2 - Prognostic significance of measurements in the coronal and transverse planes

AU - Kumar, Anita

AU - Burger, Irene A.

AU - Zhang, Zhigang

AU - Drill, Esther N.

AU - Migliacci, Jocelyn C.

AU - Ng, Andrea

AU - Lacasce, Ann

AU - Wall, Darci

AU - Witzig, Thomas E.

AU - Ristow, Kay

AU - Yahalom, Joachim

AU - Moskowitz, Craig

AU - Zelenetz, Andrew D.

PY - 2016/9/30

Y1 - 2016/9/30

N2 - Disease bulk is an important prognostic factor in early stage Hodgkin lymphoma, but its definition is unclear in the computed tomography era. This retrospective analysis investigated the prognostic significance of bulky disease measured in transverse and coronal planes on computed tomography imaging. Early stage Hodgkin lymphoma patients (n=185) treated with chemotherapy with or without radiotherapy from 2000-2010 were included. The longest diameter of the largest lymph node mass was measured in transverse and coronal axes on pre-treatment imaging. The optimal cut off for disease bulk was maximal diameter greater than 7 cm measured in either the transverse or coronal plane. Thirty patients with maximal transverse diameter of 7 cm or under were found to have bulk in coronal axis. The 4-year overall survival was 96.5% (CI: 93.3%, 100%) and 4-year relapse-free survival was 86.8% (CI: 81.9%, 92.1%) for all patients. Relapse-free survival at four years for bulky patients was 80.5% (CI: 73%, 88.9%) compared to 94.4% (CI: 89.1%, 100%) for non-bulky; Cox HR 4.21 (CI: 1.43, 12.38) (P=0.004). In bulky patients, relapse-free survival was not impacted in patients treated with chemoradiotherapy; however, it was significantly lower in patients treated with chemotherapy alone. In an independent validation cohort of 38 patients treated with chemotherapy alone, patients with bulky disease had an inferior relapse-free survival [at 4 years, 71.1% (CI: 52.1%, 97%) vs. 94.1% (CI: 83.6%, 100%), Cox HR 5.27 (CI: 0.62, 45.16); P=0.09]. Presence of bulky disease on multidimensional computed tomography imaging is a significant prognostic factor in early stage Hodgkin lymphoma. Coronal reformations may be included for routine Hodgkin lymphoma staging evaluation. In future, our definition of disease bulk may be useful in identifying patients who are most appropriate for chemotherapy alone.

AB - Disease bulk is an important prognostic factor in early stage Hodgkin lymphoma, but its definition is unclear in the computed tomography era. This retrospective analysis investigated the prognostic significance of bulky disease measured in transverse and coronal planes on computed tomography imaging. Early stage Hodgkin lymphoma patients (n=185) treated with chemotherapy with or without radiotherapy from 2000-2010 were included. The longest diameter of the largest lymph node mass was measured in transverse and coronal axes on pre-treatment imaging. The optimal cut off for disease bulk was maximal diameter greater than 7 cm measured in either the transverse or coronal plane. Thirty patients with maximal transverse diameter of 7 cm or under were found to have bulk in coronal axis. The 4-year overall survival was 96.5% (CI: 93.3%, 100%) and 4-year relapse-free survival was 86.8% (CI: 81.9%, 92.1%) for all patients. Relapse-free survival at four years for bulky patients was 80.5% (CI: 73%, 88.9%) compared to 94.4% (CI: 89.1%, 100%) for non-bulky; Cox HR 4.21 (CI: 1.43, 12.38) (P=0.004). In bulky patients, relapse-free survival was not impacted in patients treated with chemoradiotherapy; however, it was significantly lower in patients treated with chemotherapy alone. In an independent validation cohort of 38 patients treated with chemotherapy alone, patients with bulky disease had an inferior relapse-free survival [at 4 years, 71.1% (CI: 52.1%, 97%) vs. 94.1% (CI: 83.6%, 100%), Cox HR 5.27 (CI: 0.62, 45.16); P=0.09]. Presence of bulky disease on multidimensional computed tomography imaging is a significant prognostic factor in early stage Hodgkin lymphoma. Coronal reformations may be included for routine Hodgkin lymphoma staging evaluation. In future, our definition of disease bulk may be useful in identifying patients who are most appropriate for chemotherapy alone.

UR - http://www.scopus.com/inward/record.url?scp=84989352657&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84989352657&partnerID=8YFLogxK

U2 - 10.3324/haematol.2016.141846

DO - 10.3324/haematol.2016.141846

M3 - Article

C2 - 27390360

AN - SCOPUS:84989352657

VL - 101

SP - 1237

EP - 1243

JO - Haematologica

JF - Haematologica

SN - 0390-6078

IS - 10

ER -